Press release
Global Vascular Stents Market to reach USD 18,277.68 million by 2032 at a CAGR of 6.65% by 2032, Evaluates DelveInsight
DelveInsight's "Vascular Stents Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Vascular Stents companies actively working in the market.
To know more about why North America is leading the market growth in the Vascular Stents market, get a snapshot of the report Vascular Stents Market Trends
https://www.delveinsight.com/sample-request/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Stents Overview
Vascular stents are small, expandable mesh tubes used to keep blood vessels open and ensure proper blood flow. They are typically placed inside arteries or veins that have become narrowed or blocked due to conditions like atherosclerosis or peripheral artery disease. The stent is delivered to the affected area using a catheter and expanded once in place to support the vessel walls.
Vascular stents can be bare-metal, drug-eluting (coated with medication to prevent re-narrowing), or bioabsorbable (dissolve over time). They play a crucial role in treating coronary artery disease, carotid artery disease, and other vascular disorders.
DelveInsight Analysis: The global vascular stents market size was estimated at USD 11,232.93 million in 2024 and is projected to expand at a CAGR of 6.35% between 2025 and 2032, reaching USD 18,277.68 million by 2032.
Vascular Stents Market Insights
Geographically, North America is projected to hold the largest share of the vascular stents market in 2024 compared to other regions. The region's dominance is driven by a high prevalence of cardiovascular diseases, a well-developed healthcare infrastructure, and the strong presence of major market players. Additionally, rising healthcare expenditure, favorable reimbursement policies, and the swift adoption of advanced technologies further reinforce North America's leading position in the vascular stents market.
To read more about the latest highlights related to Vascular Stents, get a snapshot of the key highlights entailed in the Vascular Stents Market Insights
https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Vascular Stents Market Report
• In June 2024, Royal Philips, a global leader in health technology, announced the first implant of the Duo Venous Stent System, an implantable device used to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI), following premarket approval (PMA) from the U.S. FDA.
• In January 2024, W. L. Gore & Associates, Inc. (Gore) announced FDA approval of a lower profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft).
• In January 2024, Reflow Medical, Inc., a developer of innovative medical devices focused on cardiovascular disease, announced that it had received CE (Conformité Européenne) Mark certification in the European Union for the Bare Temporary Spur Stent System. The device was intended to treat de novo or restenotic lesions in the infrapopliteal arteries with a commercially available drug-coated balloon (DCB) to enhance drug absorption.
• Thus, owing to such developments in the market, rapid growth will be observed in the Vascular Stents market during the forecast period
Key Players in the Vascular Stents Market
Some of the key market players operating in the Vascular Stents market include- Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company., ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, SCITECH, and others.
Which MedTech key players in the Vascular Stents market are set to emerge as the trendsetter explore @ Key Vascular Stents Companies
https://www.delveinsight.com/sample-request/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Vascular Stents Market Landscape
Furthermore, ongoing advancements in polymer technologies, stent designs, and drug formulations have improved the performance and safety of drug-eluting stents, driving their increasing demand. Leading market players are also investing in next-generation drug-eluting stents with enhanced biocompatibility and bioresorbable features, further expanding the market. The combination of superior clinical benefits and continuous R&D innovations is accelerating the growth of the vascular stents market. For example, in August 2022, Medtronic launched its latest drug-eluting coronary stent, the Onyx FrontierTM, following CE Mark approval. Building on the proven performance of the Resolute OnyxTM DES, this stent features an improved delivery system aimed at enhancing deliverability and acute performance in complex cases.
Overall, these factors are expected to strengthen this segment, thereby driving the global growth of the vascular stents market.
Scope of the Vascular Stents Market Report
• Coverage: Global
• Study Period: 2022-2032
• Vascular Stents Market Segmentation By Product Type: Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, and Others], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents and Thoracic Aortic Aneurysm Stents
• Vascular Stents Market Segmentation By Type: Bare-Metal Stents and Drug-Eluting Stents), Material (Metal and Polymer
• Vascular Stents Market Segmentation By Mode of Delivery: Balloon-Expandable Stents and Self Expandable Stents
• Vascular Stents Market Segmentation By End-User: Hospitals and Ambulatory Surgical Centers
• Vascular Stents Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Vascular Stents Companies: Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, eucatech AG, MicroPort Scientific Corporation., Meril Life Sciences Pvt. Ltd., Vascular Concepts (SMT), W. L. Gore & Associates, Inc., Becton, Dickinson and Company., ENDOLOGIX LLC., Biosensors International Group, Ltd., Lombard Medical, Translumina GmbH, JOTEC GmbH, iVascular, Cordis, Cook, SCITECH, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Vascular Stents market will grow by 2032? Click to get a snapshot of the Vascular Stents Market Analysis
https://www.delveinsight.com/sample-request/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Vascular Stents Market to reach USD 18,277.68 million by 2032 at a CAGR of 6.65% by 2032, Evaluates DelveInsight here
News-ID: 4238685 • Views: …
More Releases from DelveInsight Business Research
Global Urticaria Pipeline Expands With 20+ Companies Advancing 25+ Therapies, Re …
DelveInsight's "Urticaria Pipeline Insight, 2025" report provides an in-depth overview of the current landscape of clinical development and future growth potential within the Urticaria market.
The report delivers a comprehensive commercial and clinical analysis of pipeline therapies, spanning preclinical research to marketed products. It offers detailed drug profiles covering mechanisms of action, clinical study updates, regulatory milestones, and product development activities, including technology platforms, partnerships, collaborations, acquisitions, funding, designations, and other…
Global Neurofibromatosis Type 2 Pipeline Expands With 5+ Companies Advancing 5+ …
According to DelveInsight's analysis, the global Neurofibromatosis Type 2 (NF2) pipeline consists of more than five leading companies actively advancing over five therapeutic candidates. The assessment includes a comprehensive review of ongoing clinical trials, therapy mechanisms, routes of administration, and recent development activities.
DelveInsight's "Neurofibromatosis Type 2 Pipeline Insight, 2025" report delivers an extensive overview of the current clinical landscape and future growth potential across the Neurofibromatosis Type 2 market. The…
CDMO Market Poised for 7.25% CAGR Growth by 2032, According to DelveInsight
DelveInsight's report, "Contract Development Manufacturing Organization Market Insights, Competitive Landscape and Market Forecast-2032," offers detailed insights into current and future market trends, technological advancements, key challenges, growth drivers, and barriers. It also highlights major emerging offerings and profiles key CDMO companies shaping the market.
DelveInsight's analysis indicates that the Contract Development and Manufacturing Organization (CDMO) market is expanding rapidly, driven by the rising burden of chronic diseases such as cancer, cardiovascular…
Chronic Lower Back Pain Pipeline 2025: In-depth Clinical Trials Analysis and Eme …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Lower Back Pain pipeline constitutes 10+ key companies continuously working towards developing 10+ Chronic Lower Back Pain treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Chronic Lower Back Pain Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across…
More Releases for Stent
Airway Stent/Lung Stent Market: Opportunities for Future Expansion
Airway Stent/Lung Stent Market valued at USD X.X Billion in 2024 and is projected to reach USD X.X Billion by 2032, growing at a CAGR of X.X% from 2025 to 2032.
What is the Airway Stent/Lung Stent Market and Why is It Significant?
The Airway Stent/Lung Stent market involves the production and distribution of medical devices designed to support and keep open airways in patients suffering from conditions such as tracheal stenosis,…
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lung…
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on an…
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…
